Drug intelligence / Profile preview

mesofiller + mesotox

Development stage
Preclinical
Lead developer
Mesoestetic
Modality
Recombinant Proteins and Enzymes, Peptides, Small Molecules
Administration
Intradermal, Subcutaneous
01

Overview

**mesofiller + mesotox** is a sterile, injectable, gel-based dermal filler used for temporary correction of small skin defects such as wrinkles or scars, primarily in the upper part of the face. It combines cross-linked hyaluronic acid of non-animal origin (produced via bacterial fermentation) with botulinum toxin in high dilution, alongside other mesotherapeutic ingredients. The formulation is administered intradermally or subcutaneously and works by providing hydration, volume, and subtle reduction of fine lines, sebum production, and pores, while maintaining the natural musculature of the face. The use of botulinum toxin at low concentrations allows for skin quality improvement without the “frozen” look typical of standard botox injections, while cross-linked hyaluronic acid acts as the primary filling agent. The product is designed for aesthetic purposes and is not intended for the treatment of disease. Its effects typically last for 3-6 months, with onset seen in several days[2][1][4].

Brand names
mesofiller + mesotox
Other names
mesofiller mesotoxmesofiller® mesotox
02

Targets

BoNT/A (Botulinum neurotoxin type A)

Beyond the preview

Go deeper on mesofiller + mesotox.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mesofiller + mesotox.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call